Bookmark

Add to MyYahoo RSS

Johnson and Johnson News

News on Johnson and Johnson (Ticker: JNJ) continually updated from thousands of sources around the net.

16 hrs ago | CNN

Xarelto Side Effects Lawsuit News: New Lawsuit Alleges Xarelto...

Close to 10 Xarelto side effects lawsuits have been filed in the United States against Janssen Pharmaceuticals, a division of Johnson & Johnson and Germany-based Bayer AG over its blood-thinning medication.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Scios, OrthoClinical Diagnostics, Medical Equipment

21 hrs ago | Bloomberg

Puma's Auerbach Gained on Pfizer's Breast Drug Retreat

Alan Auerbach specializes in testing drugs that Big Pharma doesn't want anymore, and that has made him a billionaire.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Science / Technology, Health, Breast Cancer, Healthcare Law, Law

Yesterday | Reuters

Europe backs new leukaemia drugs from J&J and Gilead

Two new leukaemia drugs from Johnson & Johnson and Gilead Sciences have been recommended for approval by European regulators, paving the way for formal approval in a couple of months.

Comment?

Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry, Food, J and J Snack Foods, Johnson & Johnson, Johnson and Johnson Merck Consumer Pharmaceuticals

Yesterday | Washington Examiner

Is John Podesta's patron giving bloody new meaning to the term 'dark money'?

There may be a new meaning for the term "dark money," thanks to Hansjorg Wyss, the Swiss multibillionaire who gives millions of dollars every year to fund liberal activists like Obama White House counselor John Podesta .

Comment?

Related Topix: Activism, Biotech, Medicine, Healthcare Industry

Thu Jul 24, 2014

Seeking Alpha

JNJ: Another Win Added To The Earnings Season

JNJ reported a 2.4% increase in its consumer segment revenue, led by a 9% rise from over the counter drugs, including Tylenol.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Aria Systems, Washington, PA, Fort Washington, PA, Pfizer

Heavy Duty Trucking

Baxter Healthcare's Fleet Manager Receives 2014 Fleet Safety Award

Fleet Safety Conference Chair Mike Antich, 2014 Fleet Safety Award Honoree Kristin O'Driscoll of Baxter Healthcare, and Pam Sederholm, executive director or AALA.

Comment?

Related Topix: Schaumburg, IL, Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Truckers

GigaOM

Johnson & Johnson partners with Organovo to consider 3D-printing living tissue

The partnership centers around using bioprinted tissue to discover new drugs. The announcement comes ahead of Organovo's commercial launch later this year.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Theflyonthewall.com

Organovo jumps 19% to $9.13 following agreement with J&J unit

Organovo enters 3D bio-printed tissue agreement with J&J unit Organovo announced that it has entered into an agreement with Janssen Research and Development, a pharmaceutical company of Johnson & Johnson , to evaluate the use of 3D bio-printed tissue in a drug discovery setting, outside of the company's work in 3D liver tissue for toxicity testing.

Comment?

Related Topix: Food, J and J Snack Foods, Biotech, Medicine, Healthcare Industry

Customer Interaction Solutions

Johnson & Johnson Announces $5 Billion Share Repurchase Program

ENP Newswire - 24 July 2014 Release date- 23072014 - New Brunswick, NJ - Johnson & Johnson today announced that its Board of Directors has approved the repurchase of up to $5 billion of the company's common stock.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Healthcare Industry, Aria Systems, New Brunswick, NJ

Wed Jul 23, 2014

The New Zealand Herald

What's best for baby?

Sharon Dowling, research and development manager for leading company Johnson & Johnson , shares her advice.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Mother Jones

For Lower Back Pain, You Can Skip the Tylenol

About two-thirds of adults have lower back pain at some point in their lives, and most are told to take acetaminophen, sold under brand names like Tylenol, Anacin and Panadol.

Comment?

Related Topix: Tylenol, Tempra, Acetaminophen (generic), Medicine, Health, Pain, Back Pain, Johnson & Johnson, Biotech, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry

Bloomberg

Puma Biotech Soars on Positive Breast Cancer Drug Results

Puma Biotechnology Inc. soared after the company yesterday reported positive trial results for its breast cancer drug, positioning the company as a potential takeover target.

Comment?

Related Topix: Medicine, Cancer, Health, Breast Cancer, Biotech, Science / Technology, Healthcare Law, Law, Johnson & Johnson, Healthcare Industry

TheStreet.com

Puma Shares Soar When Wall Street Misplays Expectation Game

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Mozilla, Medicine, Health, Breast Cancer, Biotech, Science / Technology, Johnson & Johnson, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry

TheStreet.com

Puma Shares Soar When Wall Street Misplays Expectation Game

Puma's experimental drug neratinib delayed the return of cancer in a large trial of women with early-stage breast cancer .

Comment?

Related Topix: Medicine, Health, Breast Cancer, Biotech, Science / Technology, Johnson & Johnson, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Business News

Hispanic Business

Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2014

We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Johnson Controls, DePuy Orthopaedics, LOC-AID Technologies, Medical Equipment, Hospital Administration, St Peters Health Care Services

Seeking Alpha

Gilead Sciences Should Report $4B In Sovaldi Sales In Q2'14

Our Q2'14 WW Sovaldi estimate is of $4.1B , and we are now expecting $12.6B for FY2014E WW Sovaldi sales.

Comment?

Related Topix: Biotech, Gilead Sciences, Medicine, Healthcare Industry

Tue Jul 22, 2014

The Motley Fool

3 Quotes From Johnson & Johnson's Conference Call You Need to Read

Here are three quotes from the call and some commentary about why they're so important.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, OrthoClinical Diagnostics, Medical Equipment, DePuy Orthopaedics, Hospital Administration, St Peters Health Care Services

Business Journal

Johnson & Johnson board approved $5B stock buyback plan

Johnson & Johnson's board of directors approved a plan for the New Jersey health-care company to repurchase up to $5 billion of its common stock.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

The Jersey Journal

Johnson & Johnson volunteers support Buck Garden in Far Hills

Johnson & Johnson 'Day of Caring' volunteers descended upon Somerset County Park Commission Leonard J. Buck Garden at 11 Layton Road in Far Hills.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Far Hills, NJ, Startups

Seeking Alpha

Retirement Strategy: Dividend Investors Have Several Ways To 'Supplement' Their Income

This ongoing series hopefully has been helpful to many individual investors who are seeking not only more income and a more secure financial future, but also to those who are just now building a portfolio and are seeking as much of an education as possible.

Comment?

Related Topix: Financial Markets, Biotech, Medicine, Healthcare Industry, ExxonMobil Chemical, Exxon Mobil, Energy, Oil & Gas, Chemicals, Restaurant Management, Mcdonalds, Apple, Startups

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••